Scinovex
article Open Access

A rare concurrence of giant cell tumor and Myasthenia gravis

International Journal of Orthopaedics Sciences · 2021 · Vol. 7(2) · pp. 752–754

Abstract

Giant Cell tumors are rare, locally aggressive tumors, seen most commonly in long bones. These benign bone tumors are usually associated with disturbance of the bony architecture whereas, myasthenia gravis is an autoimmune disorder affecting the neuromuscular junction and manifests as a generalized muscle weakness that might involve the respiratory muscles and can lead to development of other autoimmune conditions and myasthenic crisis. Here we are reporting a rare concurrence of Giant cell tumor and myasthenia gravis in a 50 year old patient in which we used sandwich technique of reconstruction, without any perioperative complications, that resulted in good functional outcome.

Bone Tumor Diagnosis and TreatmentsSoft tissue tumors and treatmentNeurofibromatosis and Schwannoma CasesMyasthenia gravisMedicinePerioperativeWeaknessNeuromuscular junctionConcurrenceMuscle weaknessGiant cellSurgeryPathology
Citations
0
FWCI
0.00
field-weighted impact
References
5
Percentile
15%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

A rare concurrence of giant cell tumor and Myasthenia gravis · Scinovex